Form 4: Tevogen Bio Holdings Director Receives Stock Grants

Victor J. Sordillo, a director at Tevogen Bio Holdings, received 240,000 restricted stock units that vested immediately and another 240,000 that will vest over four years.

Summary

• Victor J. Sordillo, a director of Tevogen Bio Holdings Inc., was granted 240,000 restricted stock units (RSUs) on December 23, 2024.
• These RSUs were granted under the company's 2024 Omnibus Incentive Plan.
• The first grant of 240,000 RSUs vested immediately upon grant, recognizing the director's past service.
• A second grant of 240,000 RSUs will vest ratably in four equal annual installments starting January 1, 2025, contingent on continued service.
• Each RSU represents a right to receive one share of Tevogen Bio Holdings common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, with no significant positive or negative implications. The grants are a positive for the director but are not unexpected.

Positives

• The immediate vesting of 240,000 RSUs acknowledges the director's past contributions.
• The vesting schedule of the second grant of 240,000 RSUs incentivizes continued service and alignment with the company's long-term goals.

Risks

• The vesting of the second grant of RSUs is contingent on the director's continued service, which could be a risk if the director leaves the company.

Future Outlook

The second grant of RSUs will vest over the next four years, contingent on the director's continued service.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize performance.

Comparison to Industry Standards

• Stock grants are a standard form of compensation for directors in publicly traded companies.
• The vesting schedule of the second grant is typical, with vesting occurring over multiple years to encourage long-term commitment.
• The immediate vesting of the first grant is less common and suggests a reward for past service.

Stakeholder Impact

• The stock grants may have a minor dilutive effect on existing shareholders.
• The grants align the director's interests with those of shareholders.

Key Dates

Keywords

restricted stock units, RSU, stock grant, director compensation, Tevogen Bio Holdings, equity incentive, insider trading